Last 12 months
Inside the activity.
4 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 0 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 23, 2017 Filed Feb 28, 2017 00:25 UTC |
Walsh DesPresident
|
GrantStock Appreciation Rights · Derivative | 50,041 | $0.00 Strike: $59.98 | $0.00 |
DisclosureSEC source: 0001209191-17-015018 · doc4.xml · derivative · entry 1 Walsh Des · CIK 0001373040 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,402 Underlying: Common Stock · 50,041 shares Expires 2024-04-30 F1 · balance_after: On April 30, 2014, the reporting person was granted an award of 83,402 stock appreciation rights ("SARs"). The amount and timing of the vesting of these SARs is dependent upon the achievement by Herbalife Ltd. (the "Company") of certain performance criteria for each of fiscal 2014, 2015 and 2016. The performance criteria for 2016 was met, resulting in 50,041 SARs which will vest on April 30, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:24 UTC |
PEZZULLO DAVIDEVP WW Operations
|
GrantStock Appreciation Rights · Derivative | 4,367 | $0.00 Strike: $62.51 | $0.00 |
DisclosureSEC source: 0001209191-17-015014 · doc4.xml · derivative · entry 2 PEZZULLO DAVID · CIK 0001311282 · EVP WW Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,367 Underlying: Common Stock · 4,367 shares Expires 2026-05-09 F2 · balance_after: On May 9, 2016, the reporting person was granted an award of 21,834 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2016 was met, resulting in 4,367 SARs which will vest on May 9, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:24 UTC |
PEZZULLO DAVIDEVP WW Operations
|
GrantStock Appreciation Rights · Derivative | 10,603 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001209191-17-015014 · doc4.xml · derivative · entry 1 PEZZULLO DAVID · CIK 0001311282 · EVP WW Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,206 Underlying: Common Stock · 10,603 shares Expires 2025-03-02 F1 · balance_after: On March 2, 2015, the reporting person was granted an award of 53,017 stock appreciation rights ("SARs"). The amount and timing of the vesting of these SARs is dependent upon the achievement by Herbalife Ltd. (the "Company") of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2016 was met, resulting in 10,603 SARs which will vest on March 2, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:24 UTC |
Okuhara GiojiVP, General Manager, Brazil
|
GrantStock Appreciation Rights · Derivative | 806 | $0.00 Strike: $62.51 | $0.00 |
DisclosureSEC source: 0001209191-17-015012 · doc4.xml · derivative · entry 2 Okuhara Gioji · CIK 0001615478 · VP, General Manager, Brazil 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 806 Underlying: Common Stock · 806 shares Expires 2026-05-09 F2 · balance_after: On May 9, 2016, the reporting person was granted an award of 4,030 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2016 was met, resulting in 806 SARs which will vest on May 9, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:24 UTC |
Okuhara GiojiVP, General Manager, Brazil
|
GrantStock Appreciation Rights · Derivative | 1,957 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001209191-17-015012 · doc4.xml · derivative · entry 1 Okuhara Gioji · CIK 0001615478 · VP, General Manager, Brazil 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,914 Underlying: Common Stock · 1,957 shares Expires 2025-03-02 F1 · balance_after: On March 2, 2015, the reporting person was granted an award of 9,787 stock appreciation rights ("SARs"). The amount and timing of the vesting of these SARs is dependent upon the achievement by Herbalife Ltd. (the "Company") of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2016 was met, resulting in 1,957 SARs which will vest on March 2, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:21 UTC |
Lamberti FrankSVP, Managing Dir. -North Asia
|
GrantStock Appreciation Rights · Derivative | 3,359 | $0.00 Strike: $62.51 | $0.00 |
DisclosureSEC source: 0001209191-17-015006 · doc4.xml · derivative · entry 2 Lamberti Frank · CIK 0001661501 · SVP, Managing Dir. -North Asia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,359 Underlying: Common Stock · 3,359 shares Expires 2026-05-09 F2 · balance_after: On May 9, 2016, the reporting person was granted an award of 16,795 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2016 was met, resulting in 3,359 SARs which will vest on May 9, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:21 UTC |
Lamberti FrankSVP, Managing Dir. -North Asia
|
GrantStock Appreciation Rights · Derivative | 1,567 | $0.00 Strike: $54.75 | $0.00 |
DisclosureSEC source: 0001209191-17-015006 · doc4.xml · derivative · entry 1 Lamberti Frank · CIK 0001661501 · SVP, Managing Dir. -North Asia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,567 Underlying: Common Stock · 1,567 shares Expires 2026-02-28 F1 · balance_after: On February 29, 2016, the reporting person was granted an award of 7,837 stock appreciation rights ("SARs"). The amount and timing of the vesting of these SARs is dependent upon the achievement by Herbalife Ltd. (the "Company") of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2016 was met, resulting in 1,567 SARs which will vest on February 28, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:20 UTC |
Hoffman Alan LEVP, Global Corporate Affairs
|
GrantStock Appreciation Rights · Derivative | 4,367 | $0.00 Strike: $62.51 | $0.00 |
DisclosureSEC source: 0001209191-17-015003 · doc4.xml · derivative · entry 2 Hoffman Alan L · CIK 0001624527 · EVP, Global Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,367 Underlying: Common Stock · 4,367 shares Expires 2026-05-09 F2 · balance_after: On May 9, 2016, the reporting person was granted an award of 21,834 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2016 was met, resulting in 4,367 SARs which will vest on May 9, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:20 UTC |
Hoffman Alan LEVP, Global Corporate Affairs
|
GrantStock Appreciation Rights · Derivative | 10,603 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001209191-17-015003 · doc4.xml · derivative · entry 1 Hoffman Alan L · CIK 0001624527 · EVP, Global Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,206 Underlying: Common Stock · 10,603 shares Expires 2025-03-02 F1 · balance_after: On March 2, 2015, the reporting person was granted an award of 53,017 stock appreciation rights ("SARs"). The amount and timing of the vesting of these SARs is dependent upon the achievement by Herbalife Ltd. (the "Company") of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2016 was met, resulting in 10,603 SARs which will vest on March 2, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:19 UTC |
Hienrich EdiSVP/Managing Director EMEA
|
GrantStock Appreciation Rights · Derivative | 3,359 | $0.00 Strike: $62.51 | $0.00 |
DisclosureSEC source: 0001209191-17-015000 · doc4.xml · derivative · entry 4 Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,359 Underlying: Common Stock · 3,359 shares Expires 2026-05-09 F4 · balance_after: On May 9, 2016, the reporting person was granted an award of 16,795 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2016 was met, resulting in 3,359 SARs which will vest on May 9, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:19 UTC |
Hienrich EdiSVP/Managing Director EMEA
|
GrantStock Appreciation Rights · Derivative | 2,500 | $0.00 Strike: $47.80 | $0.00 |
DisclosureSEC source: 0001209191-17-015000 · doc4.xml · derivative · entry 3 Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 2,500 shares Expires 2025-05-07 F3 · balance_after: On May 7, 2015, the reporting person was granted an award of 12,500 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2016 was met, resulting in 2,500 SARs which will vest on May 7, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:19 UTC |
Hienrich EdiSVP/Managing Director EMEA
|
GrantStock Appreciation Rights · Derivative | 6,525 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001209191-17-015000 · doc4.xml · derivative · entry 2 Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,050 Underlying: Common Stock · 6,525 shares Expires 2025-03-02 F2 · balance_after: On March 2, 2015, the reporting person was granted an award of 32,626 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2016 was met, resulting in 6,525 SARs which will vest on March 2, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:19 UTC |
Hienrich EdiSVP/Managing Director EMEA
|
GrantStock Appreciation Rights · Derivative | 11,547 | $0.00 Strike: $59.98 | $0.00 |
DisclosureSEC source: 0001209191-17-015000 · doc4.xml · derivative · entry 1 Hienrich Edi · CIK 0001472187 · SVP/Managing Director EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,245 Underlying: Common Stock · 11,547 shares Expires 2024-04-30 F1 · balance_after: On April 30, 2014, the reporting person was granted an award of 19,245 stock appreciation rights ("SARs"). The amount and timing of the vesting of these SARs is dependent upon the achievement by Herbalife Ltd. (the "Company") of certain performance criteria for each of fiscal 2014, 2015 and 2016. The performance criteria for 2016 was met, resulting in 11,547 SARs which will vest on April 30, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:18 UTC |
GOUDIS RICHARDChief Operating Officer
|
GrantStock Appreciation Rights · Derivative | 12,133 | $0.00 Strike: $62.51 | $0.00 |
DisclosureSEC source: 0001209191-17-014998 · doc4.xml · derivative · entry 4 GOUDIS RICHARD · CIK 0001311175 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,133 Underlying: Common Stock · 12,133 shares Expires 2026-05-09 F4 · balance_after: On May 9, 2016, the reporting person was granted an award of 60,665 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2016 was met, resulting in 12,133 SARs which will vest on May 9, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:18 UTC |
GOUDIS RICHARDChief Operating Officer
|
GrantStock Appreciation Rights · Derivative | 16,650 | $0.00 Strike: $47.80 | $0.00 |
DisclosureSEC source: 0001209191-17-014998 · doc4.xml · derivative · entry 3 GOUDIS RICHARD · CIK 0001311175 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,300 Underlying: Common Stock · 16,650 shares Expires 2025-05-07 F3 · balance_after: On May 7, 2015, the reporting person was granted an award of 83,250 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2016 was met, resulting in 16,650 SARs which will vest on May 7, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:18 UTC |
GOUDIS RICHARDChief Operating Officer
|
GrantStock Appreciation Rights · Derivative | 24,470 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001209191-17-014998 · doc4.xml · derivative · entry 2 GOUDIS RICHARD · CIK 0001311175 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,940 Underlying: Common Stock · 24,470 shares Expires 2025-03-02 F2 · balance_after: On March 2, 2015, the reporting person was granted an award of 122,349 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2016 was met, resulting in 24,470 SARs which will vest on March 2, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:18 UTC |
GOUDIS RICHARDChief Operating Officer
|
GrantStock Appreciation Rights · Derivative | 50,041 | $0.00 Strike: $59.98 | $0.00 |
DisclosureSEC source: 0001209191-17-014998 · doc4.xml · derivative · entry 1 GOUDIS RICHARD · CIK 0001311175 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,402 Underlying: Common Stock · 50,041 shares Expires 2024-04-30 F1 · balance_after: On April 30, 2014, the reporting person was granted an award of 83,402 stock appreciation rights ("SARs"). The amount and timing of the vesting of these SARs is dependent upon the achievement by Herbalife Ltd. (the "Company") of certain performance criteria for each of fiscal 2014, 2015 and 2016. The performance criteria for 2016 was met, resulting in 50,041 SARs which will vest on April 30, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:18 UTC |
Friedman Mark JGeneral Counsel
|
GrantStock Appreciation Rights · Derivative | 4,367 | $0.00 Strike: $62.51 | $0.00 |
DisclosureSEC source: 0001209191-17-014995 · doc4.xml · derivative · entry 3 Friedman Mark J · CIK 0001590024 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,367 Underlying: Common Stock · 4,367 shares Expires 2026-05-09 F3 · balance_after: On May 9, 2016, the reporting person was granted an award of 21,834 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2016 was met, resulting in 4,367 SARs which will vest on May 9, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:18 UTC |
Friedman Mark JGeneral Counsel
|
GrantStock Appreciation Rights · Derivative | 10,603 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001209191-17-014995 · doc4.xml · derivative · entry 2 Friedman Mark J · CIK 0001590024 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,206 Underlying: Common Stock · 10,603 shares Expires 2025-03-02 F2 · balance_after: On March 2, 2015, the reporting person was granted an award of 53,017 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2016 was met, resulting in 10,603 SARs which will vest on March 2, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:18 UTC |
Friedman Mark JGeneral Counsel
|
GrantStock Appreciation Rights · Derivative | 15,011 | $0.00 Strike: $59.98 | $0.00 |
DisclosureSEC source: 0001209191-17-014995 · doc4.xml · derivative · entry 1 Friedman Mark J · CIK 0001590024 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,019 Underlying: Common Stock · 15,011 shares Expires 2024-04-30 F1 · balance_after: On April 30, 2014, the reporting person was granted an award of 25,019 stock appreciation rights ("SARs"). The amount and timing of the vesting of these SARs is dependent upon the achievement by Herbalife Ltd. (the "Company") of certain performance criteria for each of fiscal 2014, 2015 and 2016. The performance criteria for 2016 was met, resulting in 15,011 SARs which will vest on April 30, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:17 UTC |
Montesino IbelisSVP/Managing Dir North America
|
GrantStock Appreciation Rights · Derivative | 2,688 | $0.00 Strike: $62.51 | $0.00 |
DisclosureSEC source: 0001209191-17-014993 · doc4.xml · derivative · entry 4 Fleming Ibelis · CIK 0001513887 · SVP/Managing Dir North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,688 Underlying: Common Stock · 2,688 shares Expires 2026-05-09 F4 · balance_after: On May 9, 2016, the reporting person was granted an award of 13,436 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2016 was met, resulting in 2,688 SARs which will vest on May 9, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:17 UTC |
Montesino IbelisSVP/Managing Dir North America
|
GrantStock Appreciation Rights · Derivative | 2,500 | $0.00 Strike: $47.80 | $0.00 |
DisclosureSEC source: 0001209191-17-014993 · doc4.xml · derivative · entry 3 Fleming Ibelis · CIK 0001513887 · SVP/Managing Dir North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 2,500 shares Expires 2025-05-07 F3 · balance_after: On May 7, 2015, the reporting person was granted an award of 12,500 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2016 was met, resulting in 2,500 SARs which will vest on May 7, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:17 UTC |
Montesino IbelisSVP/Managing Dir North America
|
GrantStock Appreciation Rights · Derivative | 6,525 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001209191-17-014993 · doc4.xml · derivative · entry 2 Fleming Ibelis · CIK 0001513887 · SVP/Managing Dir North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,050 Underlying: Common Stock · 6,525 shares Expires 2025-03-02 F2 · balance_after: On March 2, 2015, the reporting person was granted an award of 32,626 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2016 was met, resulting in 6,525 SARs which will vest on March 2, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:17 UTC |
Montesino IbelisSVP/Managing Dir North America
|
GrantStock Appreciation Rights · Derivative | 11,547 | $0.00 Strike: $59.98 | $0.00 |
DisclosureSEC source: 0001209191-17-014993 · doc4.xml · derivative · entry 1 Fleming Ibelis · CIK 0001513887 · SVP/Managing Dir North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,245 Underlying: Common Stock · 11,547 shares Expires 2024-04-30 F1 · balance_after: On April 30, 2014, the reporting person was granted an award of 19,245 stock appreciation rights ("SARs"). The amount and timing of the vesting of these SARs is dependent upon the achievement by Herbalife Ltd. (the "Company") of certain performance criteria for each of fiscal 2014, 2015 and 2016. The performance criteria for 2016 was met, resulting in 11,547 SARs which will vest on April 30, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:16 UTC |
Fernandez Calero Miguel AngelEVP, The Americas & WWD Ops
|
GrantStock Appreciation Rights · Derivative | 4,367 | $0.00 Strike: $62.51 | $0.00 |
DisclosureSEC source: 0001209191-17-014988 · doc4.xml · derivative · entry 3 Fernandez Calero Miguel Angel · CIK 0001472194 · EVP, The Americas & WWD Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,367 Underlying: Common Stock · 4,367 shares Expires 2026-05-09 F3 · balance_after: On May 9, 2016, the reporting person was granted an award of 21,834 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2016 was met, resulting in 4,367 SARs which will vest on May 9, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:16 UTC |
Fernandez Calero Miguel AngelEVP, The Americas & WWD Ops
|
GrantStock Appreciation Rights · Derivative | 10,603 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001209191-17-014988 · doc4.xml · derivative · entry 2 Fernandez Calero Miguel Angel · CIK 0001472194 · EVP, The Americas & WWD Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,206 Underlying: Common Stock · 10,603 shares Expires 2025-03-02 F2 · balance_after: On March 2, 2015, the reporting person was granted an award of 53,017 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2016 was met, resulting in 10,603 SARs which will vest on March 2, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:16 UTC |
Fernandez Calero Miguel AngelEVP, The Americas & WWD Ops
|
GrantStock Appreciation Rights · Derivative | 15,011 | $0.00 Strike: $59.98 | $0.00 |
DisclosureSEC source: 0001209191-17-014988 · doc4.xml · derivative · entry 1 Fernandez Calero Miguel Angel · CIK 0001472194 · EVP, The Americas & WWD Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,019 Underlying: Common Stock · 15,011 shares Expires 2024-04-30 F1 · balance_after: On April 30, 2014, the reporting person was granted an award of 25,019 stock appreciation rights ("SARs"). The amount and timing of the vesting of these SARs is dependent upon the achievement by Herbalife Ltd. (the "Company") of certain performance criteria for each of fiscal 2014, 2015 and 2016. The performance criteria for 2016 was met, resulting in 15,011 SARs which will vest on April 30, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:15 UTC |
DeSimone JohnChief Financial Officer
|
GrantStock Appreciation Rights · Derivative | 11,656 | $0.00 Strike: $62.51 | $0.00 |
DisclosureSEC source: 0001209191-17-014983 · doc4.xml · derivative · entry 4 DeSimone John · CIK 0001463405 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,656 Underlying: Common Stock · 11,656 shares Expires 2026-05-09 F4 · balance_after: On May 9, 2016, the reporting person was granted an award of 58,280 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2016 was met, resulting in 11,656 SARs which will vest on May 9, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:15 UTC |
DeSimone JohnChief Financial Officer
|
GrantStock Appreciation Rights · Derivative | 10,000 | $0.00 Strike: $47.80 | $0.00 |
DisclosureSEC source: 0001209191-17-014983 · doc4.xml · derivative · entry 3 DeSimone John · CIK 0001463405 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 10,000 shares Expires 2025-05-07 F3 · balance_after: On May 7, 2015, the reporting person was granted an award of 50,000 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2016 was met, resulting in 10,000 SARs which will vest on May 7, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:15 UTC |
DeSimone JohnChief Financial Officer
|
GrantStock Appreciation Rights · Derivative | 17,944 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001209191-17-014983 · doc4.xml · derivative · entry 2 DeSimone John · CIK 0001463405 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,888 Underlying: Common Stock · 17,944 shares Expires 2025-03-02 F2 · balance_after: On March 2, 2015, the reporting person was granted an award of 89,722 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2016 was met, resulting in 17,944 SARs which will vest on March 2, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:15 UTC |
DeSimone JohnChief Financial Officer
|
GrantStock Appreciation Rights · Derivative | 34,642 | $0.00 Strike: $59.98 | $0.00 |
DisclosureSEC source: 0001209191-17-014983 · doc4.xml · derivative · entry 1 DeSimone John · CIK 0001463405 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,736 Underlying: Common Stock · 34,642 shares Expires 2024-04-30 F1 · balance_after: On April 30, 2014, the reporting person was granted an award of 57,736 stock appreciation rights ("SARs"). The amount and timing of the vesting of these SARs is dependent upon the achievement by Herbalife Ltd. (the "Company") of certain performance criteria for each of fiscal 2014, 2015 and 2016. The performance criteria for 2016 was met, resulting in 34,642 SARs which will vest on April 30, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:14 UTC |
JOHNSON MICHAELDirector · Chairman & CEO
|
GrantStock Appreciation Rights · Derivative | 33,591 | $0.00 Strike: $62.51 | $0.00 |
DisclosureSEC source: 0001209191-17-014980 · doc4.xml · derivative · entry 3 JOHNSON MICHAEL · CIK 0001311173 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,591 Underlying: Common Stock · 33,591 shares Expires 2026-05-09 F3 · balance_after: On May 9, 2016, the reporting person was granted an award of 167,954 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2016 was met, resulting in 33,591 SARs which will vest on May 9, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:14 UTC |
JOHNSON MICHAELDirector · Chairman & CEO
|
GrantStock Appreciation Rights · Derivative | 81,566 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001209191-17-014980 · doc4.xml · derivative · entry 2 JOHNSON MICHAEL · CIK 0001311173 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,132 Underlying: Common Stock · 81,566 shares Expires 2025-03-02 F2 · balance_after: On March 2, 2015, the reporting person was granted an award of 407,830 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2016 was met, resulting in 81,566 SARs which will vest on March 2, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:14 UTC |
JOHNSON MICHAELDirector · Chairman & CEO
|
GrantStock Appreciation Rights · Derivative | 115,473 | $0.00 Strike: $59.98 | $0.00 |
DisclosureSEC source: 0001209191-17-014980 · doc4.xml · derivative · entry 1 JOHNSON MICHAEL · CIK 0001311173 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,455 Underlying: Common Stock · 115,473 shares Expires 2024-04-30 F1 · balance_after: On April 30, 2014, the reporting person was granted an award of 192,455 stock appreciation rights ("SARs"). The amount and timing of the vesting of these SARs is dependent upon the achievement by Herbalife Ltd. (the "Company") of certain performance criteria for each of fiscal 2014, 2015 and 2016. The performance criteria for 2016 was met, resulting in 115,473 SARs which will vest on April 30, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:13 UTC |
Conchie StephenVP, Gen. Mgr. - Southeast Asia
|
GrantStock Appreciation Rights · Derivative | 1,522 | $0.00 Strike: $67.09 | $0.00 |
DisclosureSEC source: 0001209191-17-014975 · doc4.xml · derivative · entry 2 Conchie Stephen · CIK 0001661500 · VP, Gen. Mgr. - Southeast Asia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,522 Underlying: Common Stock · 1,522 shares Expires 2026-08-05 F2 · balance_after: On August 5, 2016, the reporting person was granted an award of 7,610 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2016 was met, resulting in 1,522 SARs which will vest on August 5, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:13 UTC |
Conchie StephenVP, Gen. Mgr. - Southeast Asia
|
GrantStock Appreciation Rights · Derivative | 1,048 | $0.00 Strike: $62.51 | $0.00 |
DisclosureSEC source: 0001209191-17-014975 · doc4.xml · derivative · entry 1 Conchie Stephen · CIK 0001661500 · VP, Gen. Mgr. - Southeast Asia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,048 Underlying: Common Stock · 1,048 shares Expires 2026-05-09 F1 · balance_after: On May 9, 2016, the reporting person was granted an award of 5,240 stock appreciation rights ("SARs"). The amount and timing of the vesting of these SARs is dependent upon the achievement by Herbalife Ltd. (the "Company") of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2016 was met, resulting in 1,048 SARs which will vest on May 9, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:11 UTC |
Chiu Shin-Shing BoscoPrincipal Accounting Officer
|
GrantStock Appreciation Rights · Derivative | 1,545 | $0.00 Strike: $62.51 | $0.00 |
DisclosureSEC source: 0001209191-17-014969 · doc4.xml · derivative · entry 4 Chiu Shin-Shing Bosco · CIK 0001504597 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,545 Underlying: Common Stock · 1,545 shares Expires 2026-05-09 F4 · balance_after: On May 9, 2016, the reporting person was granted an award of 7,725 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2016 was met, resulting in 1,545 SARs which will vest on May 9, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:11 UTC |
Chiu Shin-Shing BoscoPrincipal Accounting Officer
|
GrantStock Appreciation Rights · Derivative | 4,250 | $0.00 Strike: $47.80 | $0.00 |
DisclosureSEC source: 0001209191-17-014969 · doc4.xml · derivative · entry 3 Chiu Shin-Shing Bosco · CIK 0001504597 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,500 Underlying: Common Stock · 4,250 shares Expires 2025-05-07 F3 · balance_after: On May 7, 2015, the reporting person was granted an award of 21,250 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2016 was met, resulting in 3,752 SARs which will vest on May 7, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:11 UTC |
Chiu Shin-Shing BoscoPrincipal Accounting Officer
|
GrantStock Appreciation Rights · Derivative | 3,752 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001209191-17-014969 · doc4.xml · derivative · entry 2 Chiu Shin-Shing Bosco · CIK 0001504597 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,504 Underlying: Common Stock · 3,752 shares Expires 2025-03-02 F2 · balance_after: On March 2, 2015, the reporting person was granted an award of 18,760 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2016 was met, resulting in 3,752 SARs which will vest on March 2, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:11 UTC |
Chiu Shin-Shing BoscoPrincipal Accounting Officer
|
GrantStock Appreciation Rights · Derivative | 9,237 | $0.00 Strike: $59.98 | $0.00 |
DisclosureSEC source: 0001209191-17-014969 · doc4.xml · derivative · entry 1 Chiu Shin-Shing Bosco · CIK 0001504597 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,396 Underlying: Common Stock · 9,237 shares Expires 2024-04-30 F1 · balance_after: On April 30, 2014, the reporting person was granted an award of 15,396 stock appreciation rights ("SARs"). The amount and timing of the vesting of these SARs is dependent upon the achievement by Herbalife Ltd. (the "Company") of certain performance criteria for each of fiscal 2014, 2015 and 2016. The performance criteria for 2016 was met, resulting in 9,237 SARs which will vest on April 30, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:09 UTC |
Aspauza JossieVP, SAM/CAM
|
GrantStock Appreciation Rights · Derivative | 1,048 | $0.00 Strike: $62.51 | $0.00 |
DisclosureSEC source: 0001209191-17-014966 · doc4.xml · derivative · entry 2 Aspauza Jossie · CIK 0001624298 · VP, SAM/CAM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,048 Underlying: Common Stock · 1,048 shares Expires 2026-05-09 F2 · balance_after: On May 9, 2016, the reporting person was granted an award of 5,240 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2016 was met, resulting in 1,048 SARs which will vest on May 9, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:09 UTC |
Aspauza JossieVP, SAM/CAM
|
GrantStock Appreciation Rights · Derivative | 1,957 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001209191-17-014966 · doc4.xml · derivative · entry 1 Aspauza Jossie · CIK 0001624298 · VP, SAM/CAM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,914 Underlying: Common Stock · 1,957 shares Expires 2025-03-02 F1 · balance_after: On March 2, 2015, the reporting person was granted an award of 9,787 stock appreciation rights ("SARs"). The amount and timing of the vesting of these SARs is dependent upon the achievement by Herbalife Ltd. (the "Company") of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2016 was met, resulting in 1,957 SARs which will vest on March 2, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:09 UTC |
Alvarez JesusVP, General Manager, Mexico
|
GrantStock Appreciation Rights · Derivative | 873 | $0.00 Strike: $62.51 | $0.00 |
DisclosureSEC source: 0001209191-17-014963 · doc4.xml · derivative · entry 2 Alzarez Jesus · CIK 0001615466 · VP, General Manager, Mexico 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 873 Underlying: Common Stock · 873 shares Expires 2026-05-09 F2 · balance_after: On May 9, 2016, the reporting person was granted an award of 4,366 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2016 was met, resulting in 873 SARs which will vest on May 9, 2017. Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:09 UTC |
Alvarez JesusVP, General Manager, Mexico
|
GrantStock Appreciation Rights · Derivative | 1,957 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001209191-17-014963 · doc4.xml · derivative · entry 1 Alzarez Jesus · CIK 0001615466 · VP, General Manager, Mexico 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,914 Underlying: Common Stock · 1,957 shares Expires 2025-03-02 F1 · balance_after: On March 2, 2015, the reporting person was granted an award of 9,787 stock appreciation rights ("SARs"). The amount and timing of the vesting of these SARs is dependent upon the achievement by Herbalife Ltd. (the "Company") of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2016 was met, resulting in 1,957 SARs which will vest on March 2, 2017. Read SEC document |
| November 08, 2016 Filed Nov 8, 2016 22:44 UTC |
ICAHN CARL C10% owner
HIGH RIVER LIMITED PARTNERSHIP10% owner
ICAHN PARTNERS LP10% owner
ICAHN PARTNERS MASTER FUND LP10% owner
|
PurchaseShares | 373,082 | $55.27 | $20,620,242.14 |
DisclosureSEC source: 0001140361-16-085435 · doc1.xml · nonDerivative · entry 3 ICAHN CARL C · CIK 0000921669 · 10% owner HIGH RIVER LIMITED PARTNERSHIP · CIK 0000928464 · 10% owner ICAHN PARTNERS LP · CIK 0001313666 · 10% owner ICAHN PARTNERS MASTER FUND LP · CIK 0001322827 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · please see all footnotes Disclosed balance after: 22,500,000 F1 · ownership.nature: High River Limited Partnership ("High River") directly beneficially owns 4,500,000 Shares, Icahn Partners LP ("Icahn Partners") directly beneficially owns 10,676,248 Shares, and Icahn Partners Master Fund LP ("Icahn Master") directly beneficially owns 7,323,752 Shares. F2 · ownership.nature: Barberry Corp. ("Barberry") is the sole member of Hopper Investments LLC ("Hopper"), which is the general partner of High River. Beckton Corp. ("Beckton") is the sole stockholder of Icahn Enterprises G.P. Inc. ("Icahn Enterprises GP"), which is the general partner of Icahn Enterprises Holdings L.P. ("Icahn Enterprises Holdings"). Icahn Enterprises Holdings is the sole member of IPH GP LLC ("IPH"), which is the general partner of Icahn Capital LP ("Icahn Capital"). Icahn Capital is the general partner of each of Icahn Onshore LP ("Icahn Onshore") and Icahn Offshore LP ("Icahn Offshore"). Icahn Onshore is the general partner of Icahn Partners. Icahn Offshore is the general partner of Icahn Master. F3 · ownership.nature: Each of Barberry and Beckton is 100 percent owned by Carl C. Icahn. As such, Mr. Icahn is in a position indirectly to determine the investment and voting decisions made by each of High River, Icahn Partners, and Icahn Master. Each of Hopper, Barberry and Mr. Icahn may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Act) the Shares which High River owns. Each of Hopper, Barberry and Mr. Icahn disclaims beneficial ownership of such Shares except to the extent of their pecuniary interest therein. F4 · ownership.nature: Each of Icahn Onshore, Icahn Capital, IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr. Icahn may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Act) the Shares which Icahn Partners owns. Each of Icahn Onshore, Icahn Capital, IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr. Icahn disclaims beneficial ownership of such Shares except to the extent of their pecuniary interest therein. F5 · ownership.nature: Each of Icahn Offshore, Icahn Capital, IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr. Icahn may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Act) the Shares which Icahn Master owns. Each of Icahn Offshore, Icahn Capital, IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr. Icahn disclaims beneficial ownership of such Shares except to the extent of their pecuniary interest therein. Read SEC document |
| November 07, 2016 Filed Nov 8, 2016 22:44 UTC |
ICAHN CARL C10% owner
HIGH RIVER LIMITED PARTNERSHIP10% owner
ICAHN PARTNERS LP10% owner
ICAHN PARTNERS MASTER FUND LP10% owner
|
PurchaseShares | 298,399 | $54.97 | $16,402,993.03 |
DisclosureSEC source: 0001140361-16-085435 · doc1.xml · nonDerivative · entry 2 ICAHN CARL C · CIK 0000921669 · 10% owner HIGH RIVER LIMITED PARTNERSHIP · CIK 0000928464 · 10% owner ICAHN PARTNERS LP · CIK 0001313666 · 10% owner ICAHN PARTNERS MASTER FUND LP · CIK 0001322827 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · please see all footnotes Disclosed balance after: 22,126,918 F1 · ownership.nature: High River Limited Partnership ("High River") directly beneficially owns 4,500,000 Shares, Icahn Partners LP ("Icahn Partners") directly beneficially owns 10,676,248 Shares, and Icahn Partners Master Fund LP ("Icahn Master") directly beneficially owns 7,323,752 Shares. F2 · ownership.nature: Barberry Corp. ("Barberry") is the sole member of Hopper Investments LLC ("Hopper"), which is the general partner of High River. Beckton Corp. ("Beckton") is the sole stockholder of Icahn Enterprises G.P. Inc. ("Icahn Enterprises GP"), which is the general partner of Icahn Enterprises Holdings L.P. ("Icahn Enterprises Holdings"). Icahn Enterprises Holdings is the sole member of IPH GP LLC ("IPH"), which is the general partner of Icahn Capital LP ("Icahn Capital"). Icahn Capital is the general partner of each of Icahn Onshore LP ("Icahn Onshore") and Icahn Offshore LP ("Icahn Offshore"). Icahn Onshore is the general partner of Icahn Partners. Icahn Offshore is the general partner of Icahn Master. F3 · ownership.nature: Each of Barberry and Beckton is 100 percent owned by Carl C. Icahn. As such, Mr. Icahn is in a position indirectly to determine the investment and voting decisions made by each of High River, Icahn Partners, and Icahn Master. Each of Hopper, Barberry and Mr. Icahn may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Act) the Shares which High River owns. Each of Hopper, Barberry and Mr. Icahn disclaims beneficial ownership of such Shares except to the extent of their pecuniary interest therein. F4 · ownership.nature: Each of Icahn Onshore, Icahn Capital, IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr. Icahn may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Act) the Shares which Icahn Partners owns. Each of Icahn Onshore, Icahn Capital, IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr. Icahn disclaims beneficial ownership of such Shares except to the extent of their pecuniary interest therein. F5 · ownership.nature: Each of Icahn Offshore, Icahn Capital, IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr. Icahn may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Act) the Shares which Icahn Master owns. Each of Icahn Offshore, Icahn Capital, IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr. Icahn disclaims beneficial ownership of such Shares except to the extent of their pecuniary interest therein. Read SEC document |
| November 04, 2016 Filed Nov 8, 2016 22:44 UTC |
ICAHN CARL C10% owner
HIGH RIVER LIMITED PARTNERSHIP10% owner
ICAHN PARTNERS LP10% owner
ICAHN PARTNERS MASTER FUND LP10% owner
|
PurchaseCommon Shares, par Value $0.001 per share ("Shares") | 384,588 | $54.89 | $21,110,035.32 |
DisclosureSEC source: 0001140361-16-085435 · doc1.xml · nonDerivative · entry 1 ICAHN CARL C · CIK 0000921669 · 10% owner HIGH RIVER LIMITED PARTNERSHIP · CIK 0000928464 · 10% owner ICAHN PARTNERS LP · CIK 0001313666 · 10% owner ICAHN PARTNERS MASTER FUND LP · CIK 0001322827 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Please see all footnotes Disclosed balance after: 21,828,519 F1 · ownership.nature: High River Limited Partnership ("High River") directly beneficially owns 4,500,000 Shares, Icahn Partners LP ("Icahn Partners") directly beneficially owns 10,676,248 Shares, and Icahn Partners Master Fund LP ("Icahn Master") directly beneficially owns 7,323,752 Shares. F2 · ownership.nature: Barberry Corp. ("Barberry") is the sole member of Hopper Investments LLC ("Hopper"), which is the general partner of High River. Beckton Corp. ("Beckton") is the sole stockholder of Icahn Enterprises G.P. Inc. ("Icahn Enterprises GP"), which is the general partner of Icahn Enterprises Holdings L.P. ("Icahn Enterprises Holdings"). Icahn Enterprises Holdings is the sole member of IPH GP LLC ("IPH"), which is the general partner of Icahn Capital LP ("Icahn Capital"). Icahn Capital is the general partner of each of Icahn Onshore LP ("Icahn Onshore") and Icahn Offshore LP ("Icahn Offshore"). Icahn Onshore is the general partner of Icahn Partners. Icahn Offshore is the general partner of Icahn Master. F3 · ownership.nature: Each of Barberry and Beckton is 100 percent owned by Carl C. Icahn. As such, Mr. Icahn is in a position indirectly to determine the investment and voting decisions made by each of High River, Icahn Partners, and Icahn Master. Each of Hopper, Barberry and Mr. Icahn may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Act) the Shares which High River owns. Each of Hopper, Barberry and Mr. Icahn disclaims beneficial ownership of such Shares except to the extent of their pecuniary interest therein. F4 · ownership.nature: Each of Icahn Onshore, Icahn Capital, IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr. Icahn may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Act) the Shares which Icahn Partners owns. Each of Icahn Onshore, Icahn Capital, IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr. Icahn disclaims beneficial ownership of such Shares except to the extent of their pecuniary interest therein. F5 · ownership.nature: Each of Icahn Offshore, Icahn Capital, IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr. Icahn may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Act) the Shares which Icahn Master owns. Each of Icahn Offshore, Icahn Capital, IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr. Icahn disclaims beneficial ownership of such Shares except to the extent of their pecuniary interest therein. Read SEC document |
| November 03, 2016 Filed Nov 3, 2016 21:30 UTC |
ICAHN CARL C10% owner
HIGH RIVER LIMITED PARTNERSHIP10% owner
ICAHN PARTNERS LP10% owner
ICAHN PARTNERS MASTER FUND LP10% owner
|
PurchaseCommon Shares, par Value $0.001 per share ("Shares") | 1,832,402 | $54.70 | $100,232,389.40 |
DisclosureSEC source: 0001140361-16-084791 · doc1.xml · nonDerivative · entry 1 ICAHN CARL C · CIK 0000921669 · 10% owner HIGH RIVER LIMITED PARTNERSHIP · CIK 0000928464 · 10% owner ICAHN PARTNERS LP · CIK 0001313666 · 10% owner ICAHN PARTNERS MASTER FUND LP · CIK 0001322827 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Please see all footnotes Disclosed balance after: 21,443,931 F1 · ownership.nature: High River Limited Partnership ("High River") directly beneficially owns 4,288,786 Shares, Icahn Partners LP ("Icahn Partners") directly beneficially owns 10,175,144 Shares, and Icahn Partners Master Fund LP ("Icahn Master") directly beneficially owns 6,980,001 Shares. F2 · ownership.nature: Barberry Corp. ("Barberry") is the sole member of Hopper Investments LLC ("Hopper"), which is the general partner of High River. Beckton Corp. ("Beckton") is the sole stockholder of Icahn Enterprises G.P. Inc. ("Icahn Enterprises GP"), which is the general partner of Icahn Enterprises Holdings L.P. ("Icahn Enterprises Holdings"). Icahn Enterprises Holdings is the sole member of IPH GP LLC ("IPH"), which is the general partner of Icahn Capital LP ("Icahn Capital"). Icahn Capital is the general partner of each of Icahn Onshore LP ("Icahn Onshore") and Icahn Offshore LP ("Icahn Offshore"). Icahn Onshore is the general partner of Icahn Partners. Icahn Offshore is the general partner of Icahn Master. F3 · ownership.nature: Each of Barberry and Beckton is 100 percent owned by Carl C. Icahn. As such, Mr. Icahn is in a position indirectly to determine the investment and voting decisions made by each of High River, Icahn Partners, and Icahn Master. Each of Hopper, Barberry and Mr. Icahn may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Act) the Shares which High River owns. Each of Hopper, Barberry and Mr. Icahn disclaims beneficial ownership of such Shares except to the extent of their pecuniary interest therein. F4 · ownership.nature: Each of Icahn Onshore, Icahn Capital, IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr. Icahn may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Act) the Shares which Icahn Partners owns. Each of Icahn Onshore, Icahn Capital, IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr. Icahn disclaims beneficial ownership of such Shares except to the extent of their pecuniary interest therein. F5 · ownership.nature: Each of Icahn Offshore, Icahn Capital, IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr. Icahn may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Act) the Shares which Icahn Master owns. Each of Icahn Offshore, Icahn Capital, IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr. Icahn disclaims beneficial ownership of such Shares except to the extent of their pecuniary interest therein. Read SEC document |
| August 31, 2016 Filed Sep 2, 2016 21:00 UTC |
ICAHN CARL C10% owner
HIGH RIVER LIMITED PARTNERSHIP10% owner
ICAHN PARTNERS LP10% owner
ICAHN PARTNERS MASTER FUND LP10% owner
|
PurchaseCommon Shares, per Value $0.001 per share ("Shares") | 306,846 | $60.39 | $18,530,429.94 |
DisclosureSEC source: 0001140361-16-078769 · doc1.xml · nonDerivative · entry 1 ICAHN CARL C · CIK 0000921669 · 10% owner HIGH RIVER LIMITED PARTNERSHIP · CIK 0000928464 · 10% owner ICAHN PARTNERS LP · CIK 0001313666 · 10% owner ICAHN PARTNERS MASTER FUND LP · CIK 0001322827 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Please see all footnotes Disclosed balance after: 19,611,529 F1 · ownership.nature: High River Limited Partnership ("High River") directly beneficially owns 3,922,306 Shares, Icahn Partners LP ("Icahn Partners") directly beneficially owns 9,315,068 Shares, and Icahn Partners Master Fund LP ("Icahn Master") directly beneficially owns 6,374,155 Shares. F2 · ownership.nature: Barberry Corp. ("Barberry") is the sole member of Hopper Investments LLC ("Hopper"), which is the general partner of High River. Beckton Corp. ("Beckton") is the sole stockholder of Icahn Enterprises G.P. Inc. ("Icahn Enterprises GP"), which is the general partner of Icahn Enterprises Holdings L.P. ("Icahn Enterprises Holdings"). Icahn Enterprises Holdings is the sole member of IPH GP LLC ("IPH"), which is the general partner of Icahn Capital LP ("Icahn Capital"). Icahn Capital is the general partner of each of Icahn Onshore LP ("Icahn Onshore") and Icahn Offshore LP ("Icahn Offshore"). Icahn Onshore is the general partner of Icahn Partners. Icahn Offshore is the general partner of Icahn Master. F3 · ownership.nature: Each of Barberry and Beckton is 100 percent owned by Carl C. Icahn. As such, Mr. Icahn is in a position indirectly to determine the investment and voting decisions made by each of High River, Icahn Partners, and Icahn Master. Each of Hopper, Barberry and Mr. Icahn may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Act) the Shares which High River owns. Each of Hopper, Barberry and Mr. Icahn disclaims beneficial ownership of such Shares except to the extent of their pecuniary interest therein. F4 · ownership.nature: Each of Icahn Onshore, Icahn Capital, IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr. Icahn may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Act) the Shares which Icahn Partners owns. Each of Icahn Onshore, Icahn Capital, IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr. Icahn disclaims beneficial ownership of such Shares except to the extent of their pecuniary interest therein. F5 · ownership.nature: Each of Icahn Offshore, Icahn Capital, IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr. Icahn may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Act) the Shares which Icahn Master owns. Each of Icahn Offshore, Icahn Capital, IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr. Icahn disclaims beneficial ownership of such Shares except to the extent of their pecuniary interest therein. Read SEC document |
| August 26, 2016 Filed Aug 26, 2016 21:42 UTC |
ICAHN CARL C10% owner
|
PurchaseCommon Shares, per Value $0.001 per share ("Shares") | 2,304,683 | $59.31 | $136,690,748.73 |
DisclosureSEC source: 0001140361-16-077998 · doc1.xml · nonDerivative · entry 1 ICAHN CARL C · CIK 0000921669 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Please see all footnotes Disclosed balance after: 19,304,683 F1 · ownership.nature: High River Limited Partnership ("High River") directly beneficially owns 3,860,937 Shares, Icahn Partners LP ("Icahn Partners") directly beneficially owns 9,169,322 Shares, and Icahn Partners Master Fund LP ("Icahn Master") directly beneficially owns 6,274,424 Shares. F2 · ownership.nature: Barberry Corp. ("Barberry") is the sole member of Hopper Investments LLC ("Hopper"), which is the general partner of High River. Beckton Corp. ("Beckton") is the sole stockholder of Icahn Enterprises G.P. Inc. ("Icahn Enterprises GP"), which is the general partner of Icahn Enterprises Holdings L.P. ("Icahn Enterprises Holdings"). Icahn Enterprises Holdings is the sole member of IPH GP LLC ("IPH"), which is the general partner of Icahn Capital LP ("Icahn Capital"). Icahn Capital is the general partner of each of Icahn Onshore LP ("Icahn Onshore") and Icahn Offshore LP ("Icahn Offshore"). Icahn Onshore is the general partner of Icahn Partners. Icahn Offshore is the general partner of Icahn Master. F3 · ownership.nature: Each of Barberry and Beckton is 100 percent owned by Carl C. Icahn. As such, Mr. Icahn is in a position indirectly to determine the investment and voting decisions made by each of High River, Icahn Partners, and Icahn Master. Each of Hopper, Barberry and Mr. Icahn may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Act) the Shares which High River owns. Each of Hopper, Barberry and Mr. Icahn disclaims beneficial ownership of such Shares except to the extent of their pecuniary interest therein. F4 · ownership.nature: Each of Icahn Onshore, Icahn Capital, IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr. Icahn may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Act) the Shares which Icahn Partners owns. Each of Icahn Onshore, Icahn Capital, IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr. Icahn disclaims beneficial ownership of such Shares except to the extent of their pecuniary interest therein. F5 · ownership.nature: Each of Icahn Offshore, Icahn Capital, IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr. Icahn may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Act) the Shares which Icahn Master owns. Each of Icahn Offshore, Icahn Capital, IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr. Icahn disclaims beneficial ownership of such Shares except to the extent of their pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.